Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Net Margin: 2011-2025

Historic Net Margin for Aytu Biopharma (AYTU) over the last 15 years, with Jun 2025 value amounting to 0.93%.

  • Aytu Biopharma's Net Margin rose 1185.00% to 14.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.46%, marking a year-over-year increase of 705.00%. This contributed to the annual value of 0.93% for FY2025, which is 603.00% up from last year.
  • Latest data reveals that Aytu Biopharma reported Net Margin of 0.93% as of FY2025, which was up 118.32% from 5.10% recorded in FY2024.
  • Aytu Biopharma's 5-year Net Margin high stood at 0.93% for FY2025, and its period low was 112.53% during FY2022.
  • For the 3-year period, Aytu Biopharma's Net Margin averaged around 6.72%, with its median value being 5.10% (2024).
  • Its Net Margin has fluctuated over the past 5 years, first tumbled by 3,952bps in 2021, then skyrocketed by 9,653bps in 2023.
  • MRY analysis of 5 years shows Aytu Biopharma's Net Margin stood at 88.81% in 2021, then dropped by 27bps to 112.53% in 2022, then skyrocketed by 86bps to 15.99% in 2023, then soared by 68bps to 5.10% in 2024, then surged by 118bps to 0.93% in 2025.
  • Its Net Margin stands at 0.93% for FY2025, versus 5.10% for FY2024 and 15.99% for FY2023.